Docket

37781

Idenix Pharmaceuticals, Inc. v. Gilead Pharmasset LLC, et al.

(Federal) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings

Date	Proceeding	Filed By (if applicable)
2018-05-01	Close file on Leave
2018-04-27	Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2018-04-27	Judgment on leave sent to the parties
2018-04-26	Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-483-15, 2017 FCA 161, dated July 24, 2017, is dismissed with costs. Dismissed, with costs
2018-03-26	All materials on application for leave submitted to the Judges, for consideration by the Court
2017-11-14	Applicant's reply to respondent's argument, (Book Form), Completed on: 2017-11-14	Idenix Pharmaceuticals, Inc.
2017-11-03	Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2017-11-03	Gilead Pharmasset LLC
2017-11-03	Certificate (on limitations to public access), (Letter Form), 23B	Gilead Pharmasset LLC
2017-11-03	Certificate (on limitations to public access), (Letter Form), 23A	Gilead Pharmasset LLC
2017-11-03	Notice of name, (Letter Form)	Gilead Sciences Canada, Inc.
2017-11-03	Notice of name, (Letter Form)	Gilead Pharmasset LLC
2017-11-03	Notice of name, (Letter Form)	Gilead Sciences, Inc.
2017-10-04	Letter acknowledging receipt of a complete application for leave to appeal, File opened on 2017-10-04
2017-09-29	Certificate (on limitations to public access), Form 23B	Idenix Pharmaceuticals, Inc.
2017-09-29	Certificate (on limitations to public access), Form 23A	Idenix Pharmaceuticals, Inc.
2017-09-29	Notice of name	Idenix Pharmaceuticals, Inc.
2017-09-29	Application for leave to appeal, (Book Form), Completed on: 2017-09-29	Idenix Pharmaceuticals, Inc.